PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pulmonology, Zuyderland Medical Centre, Heerlen, The Netherlands marl.janssen4@zuyderland.nl.\', \'Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.\', \'Department of Rheumatology, Zuyderland Medical Centre, Heerlen, The Netherlands.\', \'Department of Pulmonology, Zuyderland Medical Centre, Heerlen, The Netherlands.\', \'Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00190610.1136/rmdopen-2021-001906
?:doi
?:hasPublicationType
?:journal
  • RMD open
is ?:pmid of
?:pmid
?:pmid
  • 34819387
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.169
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all